Starling Oncology (STLNW) Share-based Compensation Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Share-based Compensation Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn | -97.96% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 20.58% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -155.33% |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn | 80.74% |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - | 2.90% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 195.83% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | -36.76% |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn | -44.12% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | 20.00% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 42.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.29% |
| Mar 31, 2026 | 15.64% |
| Dec 31, 2025 | 2.17% |
| Sep 30, 2025 | -57.14% |
| Jun 30, 2025 | -77.80% |
| Mar 31, 2025 | -64.33% |
| Dec 31, 2024 | -68.40% |
| Sep 30, 2024 | -48.72% |
| Jun 30, 2024 | -17.53% |
| Mar 31, 2024 | -17.68% |
| Dec 31, 2023 | -32.80% |
| Sep 30, 2023 | -28.83% |
| Jun 30, 2023 | -36.95% |
| Mar 31, 2023 | -41.95% |
| Dec 31, 2022 | -75.11% |
| Sep 30, 2022 | 10,994.92% |
| Jun 30, 2022 | 12,672.55% |
| Mar 31, 2022 | 20,264.29% |